Cologuard©, Epi proColon©, and EarlyTect© are non-invasive screening tests for colon cancer that are currently in use and rely on the methylation of genes such as BMP3, NDRG4, SEPT9, SDC2 for early detection [14]. The gene discussed is BMP3; the disease is colonic neoplasm.